Concerta and Xopenex hfa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 22 people who take Concerta and Xopenex hfa. Common interactions include fatigue among females, and alopecia among males.
The phase IV clinical study analyzes what interactions people who take Concerta and Xopenex hfa have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
22 people who take Concerta and Xopenex hfa together, and have interactions are studied.
What is Concerta?
Concerta has active ingredients of methylphenidate hydrochloride. It is used in attention deficit hyperactivity disorder. Currently, eHealthMe is studying from 23,921 Concerta users.
What is Xopenex hfa?
Xopenex hfa has active ingredients of levalbuterol tartrate. It is used in asthma. Currently, eHealthMe is studying from 2,319 Xopenex hfa users.
Number of Concerta and Xopenex hfa reports submitted per year:

Common Concerta and Xopenex Hfa drug interactions by gender *:
female:
- Fatigue
- Muscle spasms
- Osteoporosis
- Pre-existing condition improved
- Malaise
- Respiratory tract infection
- Back pain
- Drug hypersensitivity
- Food allergy
- Pain
male:
- Alopecia
- Claustrophobia
- Epilepsy
- Hypersensitivity
- Memory impairment
- Pain
- Poor quality sleep
- Self injurious behaviour
- Violence-related symptom
- Erectile dysfunction
Common Concerta and Xopenex Hfa drug interactions by age *:
0-1:
n/a
2-9:
- Violence-related symptom
- Aggression
- Anger
- Crying
- Poor quality sleep
- Self injurious behaviour
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Surgery
60+:
- Back pain
- Drug hypersensitivity
- Restless legs syndrome
- Tendonitis
Common conditions people have *:
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 86.36%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 54.55%
- Pain: 2 people, 9.09%
- Migraine (headache): 2 people, 9.09%
- High Blood Pressure: 2 people, 9.09%
- Breathing Difficulty: 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Concerta and Xopenex hfa?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Drug side effects by duration, gender and age:
- Concerta side effects (23,921 reports)
- Xopenex hfa side effects (2,319 reports)
Common Concerta drug interactions:
- Concerta and Xyrem: 1,766 reports
- Concerta and Strattera: 1,177 reports
- Concerta and Adderall: 880 reports
- Concerta and Abilify: 796 reports
- Concerta and Risperdal: 748 reports
- Concerta and Wellbutrin: 741 reports
- Concerta and Vitamin d: 614 reports
- Concerta and Cymbalta: 605 reports
- Concerta and Zoloft: 571 reports
- Concerta and Prednisone: 550 reports
Browse interactions between Concerta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Xopenex hfa drug interactions:
- Xopenex hfa and Xopenex: 2,183 reports
- Xopenex hfa and Singulair: 592 reports
- Xopenex hfa and Xyrem: 512 reports
- Xopenex hfa and Prednisone: 472 reports
- Xopenex hfa and Symbicort: 359 reports
- Xopenex hfa and Vitamin d: 355 reports
- Xopenex hfa and Gabapentin: 324 reports
- Xopenex hfa and Aspirin: 319 reports
- Xopenex hfa and Zyrtec: 317 reports
- Xopenex hfa and Omeprazole: 315 reports
Browse interactions between Xopenex hfa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride and levalbuterol tartrate (the active ingredients of Concerta and Xopenex hfa, respectively), and Concerta and Xopenex hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Concerta and Xopenex hfa.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Valsartan and Tysabri drug interaction - now
- Fosphenytoin Sodium and Metoclopramide drug interaction - 10 seconds ago
- Nattokinase and Methotrexate drug interaction - 12 seconds ago
- Intal and Conjunctivitis - 15 seconds ago
- Risedronate Sodium and Abiraterone Acetate drug interaction - 16 seconds ago
- Carvedilol and Famotidine drug interaction - 18 seconds ago
- Rasuvo and Folic Acid drug interaction - 23 seconds ago
- Nitazoxanide and Montelukast Sodium drug interaction - 28 seconds ago
- Nizoral and Anastrozole drug interaction - 30 seconds ago
- Bentyl and Magnesium Citrate drug interaction - 35 seconds ago